Pages that link to "Item:Q3435671"
From MaRDI portal
The following pages link to Optimal Estimator for the Survival Distribution and Related Quantities for Treatment Policies in Two‐Stage Randomization Designs in Clinical Trials (Q3435671):
Displaying 19 items.
- Robust methods to improve efficiency and reduce bias in estimating survival curves in randomized clinical trials (Q746638) (← links)
- Estimation of survival quantiles in two-stage randomization designs (Q1011545) (← links)
- Optimizing acute myelogenous leukemia treatment regimes via sequential structural mean models (Q2089401) (← links)
- Pattern-mixture-type estimation and testing of neuroblastoma treatment regimes (Q2320951) (← links)
- Comparing treatment policies with assistance from the structural nested mean model (Q2805172) (← links)
- Estimation of Survival Distributions of Treatment Policies in Two-Stage Randomization Designs in Clinical Trials (Q3078903) (← links)
- (Q3595698) (← links)
- Evaluation of Viable Dynamic Treatment Regimes in a Sequentially Randomized Trial of Advanced Prostate Cancer (Q4916481) (← links)
- Evaluating the Effect of Early Versus Late ARV Regimen Change if Failure on an Initial Regimen: Results From the AIDS Clinical Trials Group Study A5095 (Q4916488) (← links)
- Compound optimal allocations for survival clinical trials (Q4998797) (← links)
- Optimal dynamic treatment regimes with survival endpoints: introducing <tt>DWSurv</tt> in the <tt>R</tt> package <tt>DTRreg</tt> (Q5033454) (← links)
- A multi-treatment two stage adaptive allocation for survival outcomes (Q5078392) (← links)
- Comparison of treatment regimes with adjustment for auxiliary variables (Q5124970) (← links)
- Inference for non-regular parameters in optimal dynamic treatment regimes (Q5272530) (← links)
- Cox Regression Methods for Two-Stage Randomization Designs (Q5459584) (← links)
- Semiparametric efficient estimation of survival distributions in two-stage randomisation designs in clinical trials with censored data (Q5503384) (← links)
- Sensitivity analysis for subsequent treatments in confirmatory oncology clinical trials: A two‐stage stochastic dynamic treatment regime approach (Q6074523) (← links)
- Flexible inference of optimal individualized treatment strategy in covariate adjusted randomization with multiple covariates (Q6158220) (← links)
- On sparse representation for optimal individualized treatment selection with penalized outcome weighted learning (Q6538488) (← links)